Literature DB >> 12753648

Non-classical export of an adenovirus structural protein.

Lloyd C Trotman1, Dominik P Achermann, Stephan Keller, Monika Straub, Urs F Greber.   

Abstract

The icosahedral capsids of Adenoviruses (Ads) consist of the hexon and stabilizing proteins building the facettes, and of the vertex protein penton base (Pb) anchoring the protruding fibers. The fibers bind to the Coxsackie virus B Ad cell surface receptor (CAR) and Pb to integrins. Here we describe a novel property of the Ad2 Pb. Pb was found to leave the infected cell and, upon exit, it attached to the surrounding noninfected cells forming a radial gradient with highest Pb levels on cells adjacent to the infected cell. The producer cells remained intact until at least 30 h post infection. At this point, Pb was not recovered from the extracellular medium, suggesting that its cell-cell spread might not involve free Pb. When viral particles were released at late stages of infection, soluble Pb was found in the extracellular medium and it randomly bound to noninfected cells. Nonlytic export of Pb occurred upon transient transfection with plasmid DNA, but plasmid-encoded fiber was not exported, indicating that cell-cell spread of Pb is autonomous of infection. Pb export was not affected by Brefeldin A-induced disruption of the Golgi apparatus, suggesting that it occurred via a nonclassical mechanism. Interestingly, the coexpression of Pb and fiber leads to both Pb and fiber export, termed 'protein abduction'. We suggest that fiber abduction might support viral dissemination in infected tissues by interfering with tissue integrity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753648     DOI: 10.1034/j.1600-0854.2003.00094.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  8 in total

Review 1.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

2.  Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1.

Authors:  Hongjie Wang; Corinne Ducournau; Kamola Saydaminova; Maximilian Richter; Roma Yumul; Martin Ho; Darrick Carter; Chloé Zubieta; Pascal Fender; André Lieber
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

3.  Impact of human adenovirus type 3 dodecahedron on host cells and its potential role in viral infection.

Authors:  Pascal Fender; Kathryn Hall; Guy Schoehn; G Eric Blair
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.

Authors:  Charles Vragniau; Jens-Martin Hübner; Peter Beidler; Sucheol Gil; Kamola Saydaminova; Zhuo-Zhuang Lu; Roma Yumul; Hongjie Wang; Maximilian Richter; Pavel Sova; Charles Drescher; Pascal Fender; André Lieber
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

5.  Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.

Authors:  Samuel K Campos; M Brandon Parrott; Michael A Barry
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

6.  Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models.

Authors:  Roma Yumul; Maximilian Richter; Zhuo-Zhuang Lu; Kamola Saydaminova; Hongjie Wang; Chung-Huei Katherine Wang; Darrick Carter; André Lieber
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

Review 7.  Innate immunity to adenovirus.

Authors:  Rodinde Hendrickx; Nicole Stichling; Jorien Koelen; Lukasz Kuryk; Agnieszka Lipiec; Urs F Greber
Journal:  Hum Gene Ther       Date:  2014-04-08       Impact factor: 5.695

8.  Penton-dodecahedral particles trigger opening of intercellular junctions and facilitate viral spread during adenovirus serotype 3 infection of epithelial cells.

Authors:  Zhuo-Zhuang Lu; Hongjie Wang; Yiyi Zhang; Hua Cao; Zongyi Li; Pascal Fender; André Lieber
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.